课题基金 / 基金详情

Pressure-Induced Nucleation for the Continuous Manufacture of supramolecular assemblies

Pressure-Induced Nucleation for the Continuous Manufacture of supramolecular assemblies
用于连续制造超分子组装体的压力诱导成核
批准号:
EP/N015401/1
负责人:
Iain Oswald
金额:
$123.11万
依托单位:
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2016
资助国家:
英国
项目状态:
已结题
起止时间:
2016 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The organic solid state is at the centre of a number of key billion dollar industries from pharmaceuticals ($60 billion, 2009); pigments and dyes ($1.2 billion revenue, 2010), agrochemicals ($134 billion market, 2010), energetics (explosives and propellants; $0.5 billion revenue, 2012). Each of these industries suffers from attrition whereby the number of possible products that reach the marketplace is a fraction of those conceived and made in research labs. A stage at which materials are discarded is that of the physicochemical properties. A well-known example is in the pharmaceutical industry where it is estimated that it costs $1.6 billion to produce one drug compound which is due, in part, to the catastrophic attrition rates of drug products from bench to production line. Therefore if there was a method by which one could alter the physicochemical properties without changing the functionality of the molecules the cost for manufacture would decrease considerably. Crystal Engineering or co-crystallisation is one method by which one can alter the properties of materials by forming supramolecular assemblies. These assemblies contain more than one chemical entity but can enhance stability, solubility, colour and flow properties through the addition of the second inert component. The inclusion of a second component impacts on the three-dimensional arrangement of molecules which in turn changes the physical properties of materials. The beauty of this method is that the functionality of the molecule in question is not changed i.e. a pharmaceutical product still possesses the correct molecular geometry to bind to receptors to affect a response; the solubility of a pigment may be enhanced without the loss of its colour. Another method by which one can alter the three-dimensional structure of a material hence its physical properties is via the application of high-pressure (pressures of >1atm). High pressure has proven to be an extremely effective method for changing the 3-D structure and industrial high pressure methods are already in use for pasteurising foodstuffs e.g. chicken, shellfish, orange juice etc. One of the key disadvantages is that new high pressure forms of single-component materials, e.g. paracetamol, are not stable under normal working conditions. By coupling the two areas of science together, crystal engineering and high pressure, we will be able to create materials that are stable under normal working conditions. This proposal seeks to develop a novel manufacturing methodology by which we are able to form new materials at high pressure and feed these into an industrial scale process. This process of 'seeding' is used in industrial settings presently to ensure that a consistent product is formed from the crystallisation process, we will use this process to promote the growth of high-pressure materials under ambient conditions in both batch and continuous flow systems. The latter system would align our project to the outputs of the EPSRC Centre for Continuous Manufacture and Crystallisation. Furthermore, detailed analysis of the process and the resulting materials will be carried out so that improvements can be made in the process, such as the pressures and concentrations used, as well as the design of the assemblies themselves. The physical properties of the new materials will be investigated and will provide the feedback to improve upon the process.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3390/pharmaceutics9020016
发表时间: 2017-05-16
期刊: Pharmaceutics
影响因子: 5.4
作者: [Abbas N, Oswald IDH, Pulham CR]
通讯作者: Pulham CR
DOI: 10.1021/acs.cgd.0c00871
发表时间: 2020-10-07
期刊: Crystal growth & design
影响因子: 3.8
作者: [Bebiano SS, Ter Horst JH, Oswald IDH]
通讯作者: Oswald IDH
DOI: 10.1021/jacs.9b06634
发表时间: 2019-09-04
期刊: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
影响因子: 15
作者: [Bhardwaj, Rajni M., McMahon, Jennifer A., Reutzel-Edens, Susan M.]
通讯作者: Reutzel-Edens, Susan M.
DOI: 10.1039/c7sc01379e
发表时间: 2017-07-01
期刊: Chemical science
影响因子: 8.4
作者: [Connor LE, Morrison CA, Oswald IDH, Pulham CR, Warren MR]
通讯作者: Warren MR
7
    国内基金
    海外基金
    炎性反应中巨噬细胞激活诱导死亡(activation-induced cell death,AICD)的机理研究
    • 批准号:
      30330260
    • 项目类别:
      重点项目
    • 资助金额:
      105.0万元
    • 批准年份:
      2003
    • 负责人:
      顾军
    • 依托单位: